Your browser doesn't support javascript.
loading
Glioblastoma Surgery Imaging-Reporting and Data System: Standardized Reporting of Tumor Volume, Location, and Resectability Based on Automated Segmentations.
Kommers, Ivar; Bouget, David; Pedersen, André; Eijgelaar, Roelant S; Ardon, Hilko; Barkhof, Frederik; Bello, Lorenzo; Berger, Mitchel S; Conti Nibali, Marco; Furtner, Julia; Fyllingen, Even H; Hervey-Jumper, Shawn; Idema, Albert J S; Kiesel, Barbara; Kloet, Alfred; Mandonnet, Emmanuel; Müller, Domenique M J; Robe, Pierre A; Rossi, Marco; Sagberg, Lisa M; Sciortino, Tommaso; van den Brink, Wimar A; Wagemakers, Michiel; Widhalm, Georg; Witte, Marnix G; Zwinderman, Aeilko H; Reinertsen, Ingerid; Solheim, Ole; De Witt Hamer, Philip C.
Afiliação
  • Kommers I; Department of Neurosurgery, Amsterdam University Medical Centers, Vrije Universiteit, 1081 HV Amsterdam, The Netherlands.
  • Bouget D; Cancer Center Amsterdam, Brain Tumor Center, Amsterdam University Medical Centers, 1081 HV Amsterdam, The Netherlands.
  • Pedersen A; Department of Health Research, SINTEF Digital, NO-7465 Trondheim, Norway.
  • Eijgelaar RS; Department of Health Research, SINTEF Digital, NO-7465 Trondheim, Norway.
  • Ardon H; Department of Neurosurgery, Amsterdam University Medical Centers, Vrije Universiteit, 1081 HV Amsterdam, The Netherlands.
  • Barkhof F; Cancer Center Amsterdam, Brain Tumor Center, Amsterdam University Medical Centers, 1081 HV Amsterdam, The Netherlands.
  • Bello L; Department of Neurosurgery, Twee Steden Hospital, 5042 AD Tilburg, The Netherlands.
  • Berger MS; Department of Radiology and Nuclear Medicine, Amsterdam University Medical Centers, Vrije Universiteit, 1081 HV Amsterdam, The Netherlands.
  • Conti Nibali M; Institutes of Neurology and Healthcare Engineering, University College London, London WC1E 6BT, UK.
  • Furtner J; Neurosurgical Oncology Unit, Department of Oncology and Hemato-Oncology, Humanitas Research Hospital, Università Degli Studi di Milano, 20122 Milano, Italy.
  • Fyllingen EH; Department of Neurological Surgery, University of California San Francisco, San Francisco, CA 94143, USA.
  • Hervey-Jumper S; Neurosurgical Oncology Unit, Department of Oncology and Hemato-Oncology, Humanitas Research Hospital, Università Degli Studi di Milano, 20122 Milano, Italy.
  • Idema AJS; Department of Biomedical Imaging and Image-Guided Therapy, Medical University Vienna, 1090 Wien, Austria.
  • Kiesel B; Department of Circulation and Medical Imaging, Norwegian University of Science and Technology, NO-7491 Trondheim, Norway.
  • Kloet A; Department of Radiology and Nuclear Medicine, St. Olav's Hospital, Trondheim University Hospital, NO-7030 Trondheim, Norway.
  • Mandonnet E; Department of Neurological Surgery, University of California San Francisco, San Francisco, CA 94143, USA.
  • Müller DMJ; Department of Neurosurgery, Northwest Clinics, 1815 JD Alkmaar, The Netherlands.
  • Robe PA; Department of Neurosurgery, Medical University Vienna, 1090 Wien, Austria.
  • Rossi M; Department of Neurosurgery, Haaglanden Medical Center, 2512 VA The Hague, The Netherlands.
  • Sagberg LM; Department of Neurological Surgery, Hôpital Lariboisière, 75010 Paris, France.
  • Sciortino T; Department of Neurosurgery, Amsterdam University Medical Centers, Vrije Universiteit, 1081 HV Amsterdam, The Netherlands.
  • van den Brink WA; Cancer Center Amsterdam, Brain Tumor Center, Amsterdam University Medical Centers, 1081 HV Amsterdam, The Netherlands.
  • Wagemakers M; Department of Neurology and Neurosurgery, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands.
  • Widhalm G; Neurosurgical Oncology Unit, Department of Oncology and Hemato-Oncology, Humanitas Research Hospital, Università Degli Studi di Milano, 20122 Milano, Italy.
  • Witte MG; Department of Neurosurgery, St. Olav's Hospital, Trondheim University Hospital, NO-7030 Trondheim, Norway.
  • Zwinderman AH; Neurosurgical Oncology Unit, Department of Oncology and Hemato-Oncology, Humanitas Research Hospital, Università Degli Studi di Milano, 20122 Milano, Italy.
  • Reinertsen I; Department of Neurosurgery, Isala, 8025 AB Zwolle, The Netherlands.
  • Solheim O; Department of Neurosurgery, University Medical Center Groningen, University of Groningen, 9713 GZ Groningen, The Netherlands.
  • De Witt Hamer PC; Department of Neurosurgery, Medical University Vienna, 1090 Wien, Austria.
Cancers (Basel) ; 13(12)2021 Jun 08.
Article em En | MEDLINE | ID: mdl-34201021
ABSTRACT
Treatment decisions for patients with presumed glioblastoma are based on tumor characteristics available from a preoperative MR scan. Tumor characteristics, including volume, location, and resectability, are often estimated or manually delineated. This process is time consuming and subjective. Hence, comparison across cohorts, trials, or registries are subject to assessment bias. In this study, we propose a standardized Glioblastoma Surgery Imaging Reporting and Data System (GSI-RADS) based on an automated method of tumor segmentation that provides standard reports on tumor features that are potentially relevant for glioblastoma surgery. As clinical validation, we determine the agreement in extracted tumor features between the automated method and the current standard of manual segmentations from routine clinical MR scans before treatment. In an observational consecutive cohort of 1596 adult patients with a first time surgery of a glioblastoma from 13 institutions, we segmented gadolinium-enhanced tumor parts both by a human rater and by an automated algorithm. Tumor features were extracted from segmentations of both methods and compared to assess differences, concordance, and equivalence. The laterality, contralateral infiltration, and the laterality indices were in excellent agreement. The native and normalized tumor volumes had excellent agreement, consistency, and equivalence. Multifocality, but not the number of foci, had good agreement and equivalence. The location profiles of cortical and subcortical structures were in excellent agreement. The expected residual tumor volumes and resectability indices had excellent agreement, consistency, and equivalence. Tumor probability maps were in good agreement. In conclusion, automated segmentations are in excellent agreement with manual segmentations and practically equivalent regarding tumor features that are potentially relevant for neurosurgical purposes. Standard GSI-RADS reports can be generated by open access software.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article